[HTML][HTML] Current clinical applications of diffusion-tensor imaging in neurological disorders

WS Tae, BJ Ham, SB Pyun, SH Kang… - Journal of clinical …, 2018 - ncbi.nlm.nih.gov
Diffusion-tensor imaging (DTI) is a noninvasive medical imaging tool used to investigate the
structure of white matter. The signal contrast in DTI is generated by differences in the …

Driven to decay: excitability and synaptic abnormalities in amyotrophic lateral sclerosis

MJ Fogarty - Brain research bulletin, 2018 - Elsevier
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron (MN) disease and is
clinically characterised by the death of corticospinal motor neurons (CSMNs), spinal and …

Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

E Feneberg, P Oeckl, P Steinacker, F Verde, C Barro… - Neurology, 2018 - AAN Enterprises
Objective To examine neurofilament (Nf) concentrations according to symptom onset and
clinical diagnostic certainty categories of amyotrophic lateral sclerosis (ALS). Methods We …

Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker

J Kassubek, HP Müller, K Del Tredici, D Lulé… - Journal of Neurology …, 2018 - jnnp.bmj.com
Objective Neuropathological studies in amyotrophic lateral sclerosis (ALS) have shown a
dissemination in a regional sequence in four anatomically defined patterns. The aim of this …

The changing landscape of motor neuron disease imaging: the transition from descriptive studies to precision clinical tools

P Bede, G Querin, PF Pradat - Current opinion in neurology, 2018 - journals.lww.com
The changing landscape of motor neuron disease imaging: the... : Current Opinion in
Neurology The changing landscape of motor neuron disease imaging: the transition from …

Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses

F Agosta, EG Spinelli, M Filippi - Expert review of …, 2018 - Taylor & Francis
Introduction: Several neuroimaging techniques have been used to define in vivo markers of
pathological alterations underlying amyotrophic lateral sclerosis (ALS). Growing evidence …

Microglial activation, white matter tract damage, and disability in MS

E Rissanen, J Tuisku, T Vahlberg… - Neurology …, 2018 - AAN Enterprises
Objective To investigate the relationship of in vivo microglial activation to clinical and MRI
parameters in MS. Methods Patients with secondary progressive MS (n= 10) or relapsing …

[HTML][HTML] Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra …

M Pallebage-Gamarallage, S Foxley, RAL Menke… - BMC neuroscience, 2018 - Springer
Background Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …

[HTML][HTML] Emerging magnetic resonance imaging techniques and analysis methods in amyotrophic lateral sclerosis

AW Barritt, MC Gabel, M Cercignani… - Frontiers in neurology, 2018 - frontiersin.org
Objective markers of disease sensitive to the clinical activity, symptomatic progression, and
underlying substrates of neurodegeneration are highly coveted in amyotrophic lateral …

[HTML][HTML] Amyotrophic lateral sclerosis: the complex path to precision medicine

K Talbot, E Feneberg, J Scaber, AG Thompson… - Journal of …, 2018 - Springer
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of the
corticomotorneuronal network responsible for voluntary movement. There are well …